ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) went down by -16.46% from its latest closing price when compared to the 1-year high value of $7.25 and move down -113.24%, while ZIOP stocks collected -19.24% of loss with the last five trading sessions. Press Release reported 14 hours ago that Ziopharm Oncology Announces Pricing of Public Offering of Common Stock
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Worth an Investment?
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) scored price to earnings ratio above its average ratio, recording 5.05 times of increase in earnings at the present.
ZIOP Market Performance
ZIOP stocks went down by -19.24% for the week, with the monthly drop of -24.28% and a quarterly performance of -18.85%, while its annual performance rate touched 52.47%. The simple moving average for the period of the last 20 days is -23.77% for ZIOP stocks with the simple moving average of -29.50% for the last 200 days.
Analysts’ Opinion on ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)
Many brokerage firms have already submitted their reports for ZIOP stocks, with Raymond James repeating the rating for ZIOP shares by setting it to “Outperform”. The predicted price for ZIOP socks in the upcoming period according to Raymond James is $99 based on the research report published on August 23, 2019.
Lake Street, on the other hand, stated in their research note that they expect to see ZIOP stock at the price of $7. The rating they have provided for ZIOP stocks is “Buy” according to the report published on April 4, 2019.
Laidlaw gave “Buy” rating to ZIOP stocks, setting the target price at $7.50 in the report published on April 1, 2019.
ZIOP Stocks -28.72% Far from 50 Day Moving Average
After a stumble in the market that brought ZIOP to its low price for the period of the last 52 weeks, ZIOPHARM Oncology, Inc. was unable to take a rebound, for now settling with -53.10% of loss for the given period.
The stock volatility was left at 5.02%, however, within the period of a single month, the volatility rate increased by 6.02%, while the shares sank at the distance of -24.94% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -25.93% lower at the present time.
In the course of the last 5 trading sessions, ZIOP went down by -19.24%, which changed the moving average for the period of 200 days to the total of -18.66% of losses for the stock in comparison to the 20-day moving average settled at $4.40. In addition, ZIOPHARM Oncology, Inc. saw -27.97% in overturn over the period of a single year with a tendency to cut further losses.
ZIOP Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at ZIOPHARM Oncology, Inc. (ZIOP), starting from MAUNEY DAVID M MD, who sold 22,394 shares at the price of $4.55 back on Jan 02. After this action, Rushing now owns 195,278 shares of ZIOPHARM Oncology, Inc., valued at $101,893 with the latest closing price.
Lafond Kevin G, the SVP, Treasurer & CAO of ZIOPHARM Oncology, Inc., sold 21,570 shares at the value of $4.55 during a trade that took place back on Jan 02, which means that Lafond Kevin G is holding 63,985 shares at the value of $98,144 based on the most recent closing price.
ZIOP Stock Fundamentals
The current profitability levels are settled at -36921.92 for the present operating margin. The net margin for ZIOPHARM Oncology, Inc. stands at -36381.51. Total capital return value is set at -81.21, while invested capital returns managed to touch -80.03. Equity return holds the value 112.80%, with 100.10% for asset returns.